or Try an Advanced Search...

    Technical Analysis for VRAX - Virax Biolabs Group Limited

    Grade Last Price % Change Price Change
    F 0.76 3.99% 0.03
    VRAX closed up 3.99 percent on Wednesday, May 8, 2024, on approximately normal volume. It ran into resistance at its 50 day moving average.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical VRAX trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Calm After Storm Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Up 4 Days in a Row Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    50 DMA Resistance Bearish 3.99%
    Older End-of-Day Signals for VRAX ...

       Recent Intraday Alerts

    Alert Time
    Reversed from Up about 11 hours ago
    Possible Inside Day about 11 hours ago
    Possible Pocket Pivot about 12 hours ago
    50 DMA Resistance about 14 hours ago
    60 Minute Opening Range Breakout about 15 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    VRAX Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Virax Biolabs Group Limited is an innovative biotechnology group focused on the detection and diagnosis of viral diseases, with a particular interest in the field of immunology. Virax Biolabs Group Limited is currently developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Clinical Medicine Immunology Hepatitis B Hepatitis Virus Malaria Viral Disease Herpes Herpes Simplex Monkeypox

    Is VRAX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes
    Apr 25 Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024
    Apr 16 Virax Biolabs to Participate at ESCMID Global 2024
    Mar 15 Virax Biolabs receives Nasdaq notification letter regarding minimum bid price deficiency
    Mar 15 Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
    Dec 27 Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Dec 21 Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients
    Dec 18 Virax Biolabs' CEO James Foster Issues Letter to Shareholders
    Dec 14 Virax Biolabs announces 1-for-10 share consolidation
    Dec 14 Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation
    See more VRAX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.445
    52 Week Low 0.6
    Average Volume 33,376
    200-Day Moving Average 2.00
    50-Day Moving Average 0.78
    20-Day Moving Average 0.68
    10-Day Moving Average 0.66
    Average True Range 0.08
    RSI (14) 56.52
    ADX 20.7
    +DI 26.81
    -DI 17.06
    Chandelier Exit (Long, 3 ATRs) 0.61
    Chandelier Exit (Short, 3 ATRs) 0.83
    Upper Bollinger Bands 0.77
    Lower Bollinger Band 0.58
    Percent B (%b) 0.94
    BandWidth 27.44
    MACD Line -0.03
    MACD Signal Line -0.04
    MACD Histogram 0.0137
    Fundamentals Value
    Market Cap 1.79 Million
    Num Shares 2.36 Million
    EPS -17.70
    Price-to-Earnings (P/E) Ratio -0.04
    Price-to-Sales 25.14
    Price-to-Book 0.31
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.85
    Resistance 3 (R3) 0.85 0.82 0.83
    Resistance 2 (R2) 0.82 0.80 0.82 0.83
    Resistance 1 (R1) 0.79 0.78 0.77 0.79 0.82
    Pivot Point 0.76 0.76 0.75 0.76 0.76
    Support 1 (S1) 0.73 0.74 0.71 0.73 0.69
    Support 2 (S2) 0.70 0.72 0.70 0.69
    Support 3 (S3) 0.67 0.70 0.68
    Support 4 (S4) 0.67